Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 170

1.

LDeform: Longitudinal Deformation Analysis for Adaptive Radiotherapy of Lung Cancer.

Nadeem S, Zhang P, Rimner A, Sonke JJ, Deasy JO, Tannenbaum A.

Med Phys. 2019 Nov 6. doi: 10.1002/mp.13907. [Epub ahead of print]

PMID:
31693764
2.

Investigating the impact of patient arm position in an MR-linac on liver SBRT treatment plans.

van den Wollenberg W, de Ruiter P, Nowee ME, Jansen EPM, Sonke JJ, Fast MF.

Med Phys. 2019 Nov;46(11):5144-5151. doi: 10.1002/mp.13826. Epub 2019 Oct 4.

PMID:
31529694
3.

Safety and efficacy of reduced dose and margins to involved lymph node metastases in locally advanced NSCLC patients.

van Diessen JNA, Kwint M, Sonke JJ, Walraven I, Stam B, de Langen AJ, Knegjens J, Belderbos JSA.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33021-X. doi: 10.1016/j.radonc.2019.07.028. [Epub ahead of print]

PMID:
31431389
4.

SBRT combined with concurrent chemoradiation in stage III NSCLC: Feasibility study of the phase I Hybrid trial.

Peulen H, Franssen G, Belderbos J, van der Bijl E, Tijhuis A, Rossi M, Sonke JJ, Damen E.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33008-7. doi: 10.1016/j.radonc.2019.07.015. [Epub ahead of print]

PMID:
31431387
5.

Differences between planned and delivered dose for head and neck cancer, and their consequences for normal tissue complication probability and treatment adaptation.

Heukelom J, Kantor ME, Mohamed ASR, Elhalawani H, Kocak-Uzel E, Lin T, Yang J, Aristophanous M, Rasch CR, Fuller CD, Sonke JJ.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)33027-0. doi: 10.1016/j.radonc.2019.07.034. [Epub ahead of print]

PMID:
31431381
6.

Estimation of the α/β ratio of non-small cell lung cancer treated with stereotactic body radiotherapy.

Klement RJ, Sonke JJ, Allgäuer M, Andratschke N, Appold S, Belderbos J, Belka C, Dieckmann K, Eich HT, Flentje M, Grills I, Eble M, Hope A, Grosu AL, Semrau S, Sweeney RA, Hörner-Rieber J, Werner-Wasik M, Engenhart-Cabillic R, Ye H, Guckenberger M.

Radiother Oncol. 2019 Aug 17. pii: S0167-8140(19)32998-6. doi: 10.1016/j.radonc.2019.07.008. [Epub ahead of print]

PMID:
31431371
7.

Results of a multicentre dosimetry audit using a respiratory phantom within the EORTC LungTech trial.

Lambrecht ML, Eaton DJ, Sonke JJ, Nestle U, Peulen H, Weber DC, Verheij M, Hurkmans CW.

Radiother Oncol. 2019 Sep;138:106-113. doi: 10.1016/j.radonc.2019.06.008. Epub 2019 Jun 25.

PMID:
31252291
8.

Correcting geometric image distortions in slice-based 4D-MRI on the MR-linac.

Keesman R, van de Lindt TN, Juan-Cruz C, van den Wollenberg W, van der Bijl E, Nowee ME, Sonke JJ, van der Heide UA, Fast MF.

Med Phys. 2019 Jul;46(7):3044-3054. doi: 10.1002/mp.13602. Epub 2019 Jun 7.

PMID:
31111494
9.

Organ Function Preservation Failure after (Chemo)Radiotherapy in Head and Neck Cancer: A Retrospective Cohort Analysis.

Heukelom J, Navran A, Gouw ZAR, Tesselaar ME, Zuur CL, van Werkhoven E, Sonke JJ, Rasch CRN, Al-Mamgani A.

Otolaryngol Head Neck Surg. 2019 Aug;161(2):288-296. doi: 10.1177/0194599819846073. Epub 2019 May 7.

PMID:
31060436
10.

Adaptive Radiotherapy for Anatomical Changes.

Sonke JJ, Aznar M, Rasch C.

Semin Radiat Oncol. 2019 Jul;29(3):245-257. doi: 10.1016/j.semradonc.2019.02.007. Review.

PMID:
31027642
11.

Feasibility of Micro-Computed Tomography Imaging for Direct Assessment of Surgical Resection Margins During Breast-Conserving Surgery.

Janssen NNY, van Seijen M, Loo CE, Vrancken Peeters MTFD, Hankel T, Sonke JJ, Nijkamp J.

J Surg Res. 2019 Sep;241:160-169. doi: 10.1016/j.jss.2019.03.029. Epub 2019 Apr 23.

PMID:
31026794
12.

Pre-hydration in cisplatin-based CCRT: Effects on tumour concentrations and treatment outcome.

Aalbersberg EA, Rossi MM, de Wit-van der Veen LJ, Walraven I, van den Heuvel MM, Sonke JJ, Belderbos JS, Vogel WV.

Radiother Oncol. 2019 May;134:30-36. doi: 10.1016/j.radonc.2019.01.015. Epub 2019 Jan 31.

PMID:
31005221
13.

The Prognostic Value of Baseline 18F-FDG PET/CT in Human Papillomavirus-Positive Versus Human Papillomavirus-Negative Patients With Oropharyngeal Cancer.

Gouw ZAR, La Fontaine MD, van Kranen S, van de Kamer JB, Vogel WV, van Werkhoven E, Sonke JJ, Al-Mamgani A.

Clin Nucl Med. 2019 May;44(5):e323-e328. doi: 10.1097/RLU.0000000000002531.

PMID:
30889002
14.

Predictive Models to Determine Clinically Relevant Deviations in Delivered Dose for Head and Neck Cancer.

McCulloch MM, Lee C, Rosen BS, Kamp JD, Lockhart CM, Lee JY, Polan DF, Hawkins PG, Anderson CJR, Heukelom J, Sonke JJ, Fuller CD, Balter JM, Ten Haken RK, Eisbruch A, Brock KK.

Pract Radiat Oncol. 2019 Jul - Aug;9(4):e422-e431. doi: 10.1016/j.prro.2019.02.014. Epub 2019 Mar 2.

PMID:
30836190
15.

Modeling radiation pneumonitis of pulmonary stereotactic body radiotherapy: The impact of a local dose-effect relationship for lung perfusion loss.

Selvaraj J, Lebesque J, Hope A, Guckenberger M, Werner-Wasik M, Peulen H, Giuliani M, Mantel F, Belderbos J, Grills I, Sonke JJ.

Radiother Oncol. 2019 Mar;132:142-147. doi: 10.1016/j.radonc.2018.12.015. Epub 2019 Jan 9.

PMID:
30825963
16.

Recurrent inference machines for reconstructing heterogeneous MRI data.

Lønning K, Putzky P, Sonke JJ, Reneman L, Caan MWA, Welling M.

Med Image Anal. 2019 Apr;53:64-78. doi: 10.1016/j.media.2019.01.005. Epub 2019 Jan 18.

PMID:
30703579
17.

Magnetic Resonance-based Response Assessment and Dose Adaptation in Human Papilloma Virus Positive Tumors of the Oropharynx treated with Radiotherapy (MR-ADAPTOR): An R-IDEAL stage 2a-2b/Bayesian phase II trial.

Bahig H, Yuan Y, Mohamed ASR, Brock KK, Ng SP, Wang J, Ding Y, Hutcheson K, McCulloch M, Balter PA, Lai SY, Al-Mamgani A, Sonke JJ, van der Heide UA, Nutting C, Li XA, Robbins J, Awan M, Karam I, Newbold K, Harrington K, Oelfke U, Bhide S, Philippens MEP, Terhaard CHJ, McPartlin AJ, Blanchard P, Garden AS, Rosenthal DI, Gunn GB, Phan J, Cazoulat G, Aristophanous M, McSpadden KK, Garcia JA, van den Berg CAT, Raaijmakers CPJ, Kerkmeijer L, Doornaert P, Blinde S, Frank SJ, Fuller CD.

Clin Transl Radiat Oncol. 2018 Aug 24;13:19-23. doi: 10.1016/j.ctro.2018.08.003. eCollection 2018 Nov.

18.

The acute and late toxicity results of a randomized phase II dose-escalation trial in non-small cell lung cancer (PET-boost trial).

van Diessen J, De Ruysscher D, Sonke JJ, Damen E, Sikorska K, Reymen B, van Elmpt W, Westman G, Fredberg Persson G, Dieleman E, Bjorkestrand H, Faivre-Finn C, Belderbos J.

Radiother Oncol. 2019 Feb;131:166-173. doi: 10.1016/j.radonc.2018.09.019. Epub 2018 Oct 13.

PMID:
30327236
19.

Radiation-Induced Lung Density Changes on CT Scan for NSCLC: No Impact of Dose-Escalation Level or Volume.

Defraene G, La Fontaine M, van Kranen S, Reymen B, Belderbos J, Sonke JJ, De Ruysscher D.

Int J Radiat Oncol Biol Phys. 2018 Nov 1;102(3):642-650. doi: 10.1016/j.ijrobp.2018.06.038. Epub 2018 Jul 2.

PMID:
30244882
20.

Tumor Trailing for Liver SBRT on the MR-Linac.

Fast M, van de Schoot A, van de Lindt T, Carbaat C, van der Heide U, Sonke JJ.

Int J Radiat Oncol Biol Phys. 2019 Feb 1;103(2):468-478. doi: 10.1016/j.ijrobp.2018.09.011. Epub 2018 Sep 20.

PMID:
30243573

Supplemental Content

Loading ...
Support Center